Related Experiment Videos

Development of aggressive plasma cell leukaemia under interferon-alpha therapy

J Bladé¹, A López-Guillermo, D Tassies

¹Postgraduate School of Haematology Farreras Valentí, Hospital Clinic i Provincial, University of Barcelona, Spain.

British Journal of Haematology

|November 1, 1991

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO.

British journal of haematology·2023

Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group.

Annals of hematology·2020

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma.

Oncogene·2018

Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia.

Leukemia·2017

See all related articles